UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effect of shigella enterotoxin 1 (ShET1) on rabbit intestine in vitro and in vivo

Gut, 1997-04, Vol.40 (4), p.505-511

1997

Volltextzugriff (PDF)

Strategy for Cross-Protection among Shigella flexneri Serotypes

Infection and Immunity, 1999-02, Vol.67 (2), p.782-788

1999

Volltextzugriff (PDF)

Shigella flexneri 2a strain CVD 1207, with specific deletions in virG, sen, set, and guaBA, is highly attenuated in humans

Infection and immunity, 2000-03, Vol.68 (3), p.1034-1039

2000

Volltextzugriff (PDF)

Prevalence of Shigella enterotoxin 1 among Shigella clinical isolates of diverse serotypes

The Journal of infectious diseases, 1995-11, Vol.172 (5), p.1408-1410

1995

Volltextzugriff (PDF)

Constitutive expression of the Vi polysaccharide capsular antigen in attenuated Salmonella enterica serovar Typhi oral vaccine strain CVD 909

Infection and immunity, 2000-08, Vol.68 (8), p.4647-4652

2000

Volltextzugriff (PDF)

Salmonella typhi vaccine strain CVD 908 expressing the circumsporozoite protein of Plasmodium falciparum: strain construction and safety and immunogenicity in humans

The Journal of infectious diseases, 1994-04, Vol.169 (4), p.927-931

1994

Volltextzugriff (PDF)

Further characterization of delta aroA delta virG Shigella flexneri 2a strain CVD 1203 as a mucosal Shigella vaccine and as a live-vector vaccine for delivering antigens of enterotoxigenic Escherichia coli

Infection and Immunity, 1996-01, Vol.64 (1), p.23-27

1996

Volltextzugriff (PDF)

Construction and characterization of attenuated delta aroA delta virG Shigella flexneri 2a strain CVD 1203, a prototype live oral vaccine

Infection and Immunity, 1994-11, Vol.62 (11), p.5168-5172

1994

Volltextzugriff (PDF)

Immunogenicity of a Salmonella typhi CVD 908 candidate vaccine strain expressing the major surface protein gp63 of Leishmania mexicana mexicana

Vaccine, 1998-05, Vol.16 (9), p.1043-1052

1998

Volltextzugriff (PDF)

Construction, Genotypic and Phenotypic Characterization, and Immunogenicity of Attenuated ΔguaBA Salmonella enterica Serovar Typhi Strain CVD 915

Infection and Immunity, 2001-08, Vol.69 (8), p.4734-4741

2001

Volltextzugriff (PDF)

Attenuated ΔguaBA Salmonella typhi Vaccine Strain CVD 915 as a Live Vector Utilizing Prokaryotic or Eukaryotic Expression Systems to Deliver Foreign Antigens and Elicit Immune Responses

Clinical immunology (Orlando, Fla.), 1999-07, Vol.92 (1), p.76-89

1999

Volltextzugriff (PDF)

Shigella enterotoxin 1: an enterotoxin of Shigella flexneri 2a active in rabbit small intestine in vivo and in vitro

The Journal of clinical investigation, 1995-06, Vol.95 (6), p.2853-2861

1995

Volltextzugriff (PDF)

Engineered ΔguaB-A ΔvirG Shigella flexneri 2a strain CVD 1205 : Construction, safety, immunogenicity, and potential efficacy as a mucosal vaccine

Infection and immunity, 1996, Vol.64 (8), p.3055-3061

1996

Volltextzugriff (PDF)

Toxoplasma gondii maintenance in tissue culture: a new efficient method for culturing RH tachyzoites

The Journal of parasitology, 1988-06, Vol.74 (3), p.495-499

1988

Volltextzugriff (PDF)

Engineered deltaguaB-A deltavirG Shigella flexneri 2a strain CVD 1205: construction, safety, immunogenicity, and potential efficacy as a mucosal vaccine

Infection and Immunity, 1996-08, Vol.64 (8), p.3055-3061

1996

Volltextzugriff (PDF)

Treatment of gastrointestinal infections

Current opinion in gastroenterology, 1992-02, Vol.8 (1), p.128-133

1992

Volltextzugriff (PDF)

Δ guaBA attenuated Shigella flexneri 2a strain CVD 1204 as a Shigella vaccine and as a live mucosal delivery system for fragment C of tetanus toxin

Vaccine, 2000-04, Vol.18 (21), p.2193-2202

2000

Volltextzugriff (PDF)

DeltaguaBA attenuated Shigella flexneri 2a strain CVD 1204 as a Shigella vaccine and as a live mucosal delivery system for fragment C of tetanus toxin

Vaccine, 2000-04, Vol.18 (21), p.2193

2000

Volltextzugriff (PDF)

Aguaba attenuated Shigella flexneri 2a strain CVD 1204 as a Shigella vaccine and as a live mucosal delivery system for fragment C of tetanus toxin

Vaccine, 2000, Vol.18 (21), p.2193-2202

2000

Volltextzugriff (PDF)

Construction, genotypic and phenotypic characterization, and immunogenicity of attenuated DeltaguaBA Salmonella enterica serovar Typhi strain CVD 915

Infection and immunity, 2001-08, Vol.69 (8), p.4734

2001

Volltextzugriff (PDF)

Attenuated deltaguaBA Salmonella typhi vaccine strain CVD 915 as a live vector utilizing prokaryotic or eukaryotic expression systems to deliver foreign antigens and elicit immune responses

Clinical immunology (Orlando, Fla.), 1999-07, Vol.92 (1), p.76-89

1999

Volltextzugriff (PDF)

Construction and characterization of attenuated ΔaroA ΔvirG Shigella flexneri 2a strain CBD 1203, a prototype live oral vaccine

Infection and immunity, 1994, Vol.62 (11), p.5168-5172

1994

Volltextzugriff (PDF)

16 NEW VIRULENCE FACTORS ELABORATED BY SHIGELLA FLEXNERI 2a

Journal of pediatric gastroenterology and nutrition, 1995-05, Vol.20 (4), p.449

1995

Volltextzugriff (PDF)

16 NEW VIRULENCE FACTORS ELABORATED BY SHIGELLA FLEXNERI 2a

Journal of pediatric gastroenterology and nutrition, 1995-05, Vol.20 (4), p.449-449

1995

Volltextzugriff (PDF)

Nosocomial bacteremia caused by Enterobacter sakazakiki and Leuconostoc mesenteroides resulting from extrinsic contamination of infant formula

The Pediatric infectious disease journal, 1990-06, Vol.9 (6), p.447

1990

Volltextzugriff (PDF)

1 – 25 von 422

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(385)
Mit Volltextzugriff
(353)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(253)
Ingenta
(152)
MEDLINE
(151)
Single Journals
(116)
Journals@Ovid Complete
(94)
Elsevier ScienceDirect Journals Complete
(88)
Springer Journals
(53)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(46)
IngentaConnect Journals
(34)
Wiley Online Library Journals Frontfile Complete
(29)
Oxford journals
(24)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(19)
American Physical Society
(18)
Oxford Journals 2020 Medicine
(17)
JSTOR
(14)
Wiley Online Library
(13)
Nature
(12)
PROLA
(12)
BMJ
(7)
BMJ Journals Archiv - DFG Nationallizenzen
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Effect of shigella enterotoxin 1 (ShET1) on rabbit intestine in vitro and in vivo

Strategy for Cross-Protection among Shigella flexneri Serotypes

Shigella flexneri 2a strain CVD 1207, with specific deletions in virG, sen, set, and guaBA, is highly attenuated in humans

Prevalence of Shigella enterotoxin 1 among Shigella clinical isolates of diverse serotypes

Constitutive expression of the Vi polysaccharide capsular antigen in attenuated Salmonella enterica serovar Typhi oral vaccine strain CVD 909

Salmonella typhi vaccine strain CVD 908 expressing the circumsporozoite protein of Plasmodium falciparum: strain construction and safety and immunogenicity in humans

Further characterization of delta aroA delta virG Shigella flexneri 2a strain CVD 1203 as a mucosal Shigella vaccine and as a live-vector vaccine for delivering antigens of enterotoxigenic Escherichia coli

Construction and characterization of attenuated delta aroA delta virG Shigella flexneri 2a strain CVD 1203, a prototype live oral vaccine

Immunogenicity of a Salmonella typhi CVD 908 candidate vaccine strain expressing the major surface protein gp63 of Leishmania mexicana mexicana

Construction, Genotypic and Phenotypic Characterization, and Immunogenicity of Attenuated ΔguaBA Salmonella enterica Serovar Typhi Strain CVD 915

Attenuated ΔguaBA Salmonella typhi Vaccine Strain CVD 915 as a Live Vector Utilizing Prokaryotic or Eukaryotic Expression Systems to Deliver Foreign Antigens and Elicit Immune Responses

Shigella enterotoxin 1: an enterotoxin of Shigella flexneri 2a active in rabbit small intestine in vivo and in vitro

Engineered ΔguaB-A ΔvirG Shigella flexneri 2a strain CVD 1205 : Construction, safety, immunogenicity, and potential efficacy as a mucosal vaccine

Toxoplasma gondii maintenance in tissue culture: a new efficient method for culturing RH tachyzoites

Engineered deltaguaB-A deltavirG Shigella flexneri 2a strain CVD 1205: construction, safety, immunogenicity, and potential efficacy as a mucosal vaccine

Treatment of gastrointestinal infections

Δ guaBA attenuated Shigella flexneri 2a strain CVD 1204 as a Shigella vaccine and as a live mucosal delivery system for fragment C of tetanus toxin

DeltaguaBA attenuated Shigella flexneri 2a strain CVD 1204 as a Shigella vaccine and as a live mucosal delivery system for fragment C of tetanus toxin

Aguaba attenuated Shigella flexneri 2a strain CVD 1204 as a Shigella vaccine and as a live mucosal delivery system for fragment C of tetanus toxin

Construction, genotypic and phenotypic characterization, and immunogenicity of attenuated DeltaguaBA Salmonella enterica serovar Typhi strain CVD 915

Attenuated deltaguaBA Salmonella typhi vaccine strain CVD 915 as a live vector utilizing prokaryotic or eukaryotic expression systems to deliver foreign antigens and elicit immune responses

Construction and characterization of attenuated ΔaroA ΔvirG Shigella flexneri 2a strain CBD 1203, a prototype live oral vaccine

16 NEW VIRULENCE FACTORS ELABORATED BY SHIGELLA FLEXNERI 2a

16 NEW VIRULENCE FACTORS ELABORATED BY SHIGELLA FLEXNERI 2a

Nosocomial bacteremia caused by Enterobacter sakazakiki and Leuconostoc mesenteroides resulting from extrinsic contamination of infant formula

Suchergebnisse filtern